CIDRAP newsletters options
Also, the WHO details COVAX rollout and hot spot nations that contributed to a weekly rise in cases, the first in 6 weeks.
Two doses of the Pfizer vaccine were 85% to 90% effective against symptomatic illness in those 70 and older.
Low-resource nations have borne the brunt of shaky oxygen supply chains, even before COVID.
The Centers for Disease Control and Prevention (CDC) confirmed a new case of Listeria monocytogenes in an outbreak associated with queso fresco made by El Abuelito Cheese Inc, raising the total number of cases to 11.
After vaccination with an mRNA-based COVID-19 shot, antibody levels for immunoglobulin G (IgG) were higher in the short term in healthcare workers (HCWs) who had previous COVID-19 infections than those who had never had the disease, according to a research letter published yesterday in JAMA.
A review of 10 studies finds the therapy doesn't improve survival or clinical status or shorten hospital stays.
After a 6-week decline, global COVID-19 cases are on the rise again, a worrisome development.
Instead of taking samples before and after travel, the researchers assessed daily samples.
The Guinea outbreak has reached 17 cases, and the CDC has issued public health and travel-related measures.
Availability of the J&J vaccine will be limited for weeks.
CARB-X announced today that it is awarding more than $10 million to GSK to develop vaccines to prevent serious infections caused by common bacterial pathogens that pose a significant health threat in the developing world.
Israel's national COVID-19 vaccine rollout, which saw 84% of people 70 and older fully vaccinated by Feb 9 , was associated with less need for mechanical ventilation in the elderly. The finding could show that COVID-19 vaccine rollouts help prevent severe cases at the national level, according to a study in Morbidity and Mortality Weekly Report.
Once the CDC gives the nod, distribution will start this week, with 2 million doses allocated to states.
The move gives the US a third vaccine to fight the pandemic—one that offers an easier, one-dose option that does not have to be frozen.
Now open for public comment, the WHO-led roadmap has 14 goals.
"We are left with evidence of benefit from interleukin-6 inhibitors, at least under some circumstances."
Now, it's up to FDA officials to make a final decision, which could come tomorrow.
Ten percent of cases are now caused by B117, up from 1% to 4% a few weeks ago.
In addition to less antibiotic use, participating hospitals saw a 20% drop in hospital-onset C difficile.
Five residents of a skilled nursing facility in Kentucky were likely reinfected with COVID-19, and the disease was worse the second time, with one patient dying, according to today's Morbidity and Mortality Weekly Report (MMWR).
